TNFSF10 and cancer: Cell-based functional assays confirm that AsPC1 and Panc1 cancer cells are resistant to TRAIL-induced apoptosis, and show that co-treatment of TRAIL with nimesulide confers dose-dependent TRAIL sensitivity (as measured by caspase-8 activation).